Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
13.00
+0.54 (4.38%)
At close: Apr 29, 2026, 4:00 PM EDT
12.89
-0.11 (-0.85%)
After-hours: Apr 29, 2026, 5:46 PM EDT
Cue Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -26.6 | -40.67 | -50.73 | -53.01 | -44.16 | |
| Depreciation & Amortization | 3.48 | 2.35 | 3.44 | 1.81 | 1.26 | |
| Other Amortization | 0.04 | 0.04 | 0.04 | 0.03 | - | |
| Loss (Gain) From Sale of Assets | 0.03 | -0.09 | 0.16 | 0 | -0.02 | |
| Loss (Gain) From Sale of Investments | -0.21 | - | -0.23 | -0.32 | -0 | |
| Stock-Based Compensation | 4.74 | 6.85 | 8.18 | 9.5 | 11.52 | |
| Other Operating Activities | 0.13 | 0.13 | 0.13 | -0.17 | -3.04 | |
| Change in Accounts Receivable | -4.6 | 0.75 | -1.64 | 3.09 | -1.73 | |
| Change in Accounts Payable | 1.13 | -0.68 | 0.77 | 0.08 | 0.52 | |
| Change in Unearned Revenue | 5.25 | -2.03 | 2.11 | -0.65 | -7.97 | |
| Change in Other Net Operating Assets | -5.07 | -2.97 | -2.18 | -2.17 | 4.79 | |
| Operating Cash Flow | -21.69 | -36.33 | -39.96 | -41.81 | -38.84 | |
| Capital Expenditures | -0.18 | -0.07 | - | -0.17 | -0.91 | |
| Sale of Property, Plant & Equipment | 0.04 | 0.1 | 0 | 0.01 | 0.02 | |
| Investment in Securities | 0.21 | - | 25 | -24.45 | 10 | |
| Investing Cash Flow | 0.08 | 0.03 | 25 | -24.61 | 9.11 | |
| Long-Term Debt Issued | - | - | - | 10 | - | |
| Long-Term Debt Repaid | -4.5 | -4 | -2 | - | - | |
| Net Debt Issued (Repaid) | -4.5 | -4 | -2 | 10 | - | |
| Issuance of Common Stock | 30.79 | 14.24 | 13.86 | 39.3 | 19.98 | |
| Repurchase of Common Stock | - | - | - | -0.2 | -0.75 | |
| Other Financing Activities | - | - | - | 4.56 | - | |
| Financing Cash Flow | 26.29 | 10.24 | 11.86 | 53.66 | 19.23 | |
| Net Cash Flow | 4.68 | -26.05 | -3.1 | -12.76 | -10.5 | |
| Free Cash Flow | -21.86 | -36.4 | -39.96 | -41.98 | -39.75 | |
| Free Cash Flow Margin | -79.60% | -391.89% | -727.89% | -3371.65% | -266.04% | |
| Free Cash Flow Per Share | -6.92 | -19.38 | -26.20 | -35.33 | -38.12 | |
| Cash Interest Paid | 0.21 | 0.67 | 1 | 0.57 | - | |
| Cash Income Tax Paid | - | - | - | - | 0.5 | |
| Levered Free Cash Flow | -9.95 | -20.36 | -19.91 | -21.09 | -20.32 | |
| Unlevered Free Cash Flow | -9.77 | -19.9 | -19.17 | -20.68 | -20.32 | |
| Change in Working Capital | -3.3 | -4.93 | -0.93 | 0.36 | -4.39 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.